This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van der Hage JA et al. (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224–4237
Fisher B et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672–2685
Hutcheon AW et al. (2003) Neoadjuvant docetaxel in locally advanced breast cancer. Breast Cancer Res Treat 79 (Suppl 1): S19–S24
Warren RM et al. (2004) Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90: 1349–1360
Guo XL et al. (2003) Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 9: 1995–1998
Martincich L et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83: 67–76
Douek M et al. (1998) Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet 351: 801–802
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- NEOADJUVANT CHEMOTHERAPY
-
Chemotherapy given to patients before surgery
- RECIST CRITERIA
-
Criteria for measuring tumor shrinkage as an indicator of antitumor activity, as evaluated by the Response Evaluation Criteria in Solid Tumors Group (RECIST)
- PRIMARY MEDICAL THERAPY
-
Treatment given to reduce tumor size prior to surgery, which may include chemotherapy or radiotherapy. Synonym for neoadjuvant therapy.
Rights and permissions
About this article
Cite this article
Douek, M., Tobias, J. How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?. Nat Rev Clin Oncol 2, 128–129 (2005). https://doi.org/10.1038/ncponc0105
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0105
This article is cited by
-
Optical tomography of breast cancer—monitoring response to primary medical therapy
Targeted Oncology (2009)